Montpellier, France

Muriel Amblard

This inventor holds 1 USPTO granted patent. Top assignee: Fournier Industrie Et Sante. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muriel Amblard. Retrieved from https://idiyas.com/inventor/muriel-amblard-li30iee9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Muriel Amblard: Innovator in Peptide Agonists

Introduction

Muriel Amblard is a distinguished inventor based in Montpellier, France. She has made significant contributions to the field of biochemistry, particularly in the development of peptide agonists for the bradykinin B2 receptor. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Muriel holds a patent for "Peptide agonists of bradykinin B2 receptor." This invention is pivotal in understanding and potentially treating various medical conditions related to the bradykinin system. The patent reflects her commitment to research and innovation in the pharmaceutical industry.

Career Highlights

Muriel Amblard is currently employed at Fournier Industrie Et Santé, a company known for its focus on health and pharmaceutical products. Her role at the company allows her to apply her knowledge and skills in a practical setting, contributing to the development of new therapeutic solutions.

Collaborations

Throughout her career, Muriel has collaborated with notable colleagues, including Pierre Dodey and Jean-Michel Luccarini. These partnerships have enriched her research and have been instrumental in the success of her projects.

Conclusion

Muriel Amblard is a remarkable inventor whose work in peptide agonists has the potential to impact the medical field significantly. Her dedication to innovation and collaboration exemplifies the spirit of scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…